Are Wall Street Analysts Bullish on Zimmer Biomet Stock? Zimmer Biomet Holdings, Inc. , a Warsaw, Indiana based medical device company, has seen its shares underperform the broader market over the past year.
The company's stock price has declined 3. 5% over the past 12 months, while the S&P 500 Index has rallied nearly 20. 6%. This underperformance is particularly notable given Zimmer Biomet's strong domestic momentum.
The company's "hip triple play" strategy, which involves expanding its share of the U. S. hip market through a combination of sales and marketing efforts, has been a key driver of growth.